You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resected early stage Non-small Cell Lung Cancer

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023

An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort

Enrolling by invitation
  • Chronic Obstructive Pulmonary Disease
  • +2 more
    • Lund, Sweden
      Skåne University Hospital
    Jan 12, 2022

    Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Anchorage, Alaska
    • +495 more
    Jun 15, 2022

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in United States (Palbociclib + Letrozole or Fulvestrant)

    Completed
    Has Results
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Palbociclib + Letrozole or Fulvestrant
    • Washington, District of Columbia
    • +5 more
    Sep 7, 2021

    Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,

    Recruiting
    • Oligometastatic Prostate Carcinoma
    • +2 more
    • Placebo Administration
    • +3 more
    • Decatur, Illinois
    • +2 more
    Aug 11, 2022

    Postoperative Recurrence Monitoring of Colorectal Cancer

    Recruiting
    • Colorectal Cancer
      • Beijing, Beijing, China
        Cancer hospital Chinese academy of medical sciences
      Jul 1, 2022

      Parkinson Disease Trial in Toronto (Real TUS, Real FES, Sham TUS)

      Recruiting
      • Parkinson Disease
      • Real TUS
      • +3 more
      • Toronto, Ontario, Canada
        Toronto Western Hospital
      Oct 18, 2023

      Smoke Inhalation Injury, Acute Lung Injury Trial in Cairo (Heparin, Normal Saline)

      Recruiting
      • Smoke Inhalation Injury
      • Acute Lung Injury
      • Cairo, Egypt
        Ain Shams University Hospitals
      May 31, 2023

      Tumor, Breast Trial in Seoul (Scalp cooling system 2)

      Completed
      • Neoplasm, Breast
      • Scalp cooling system 2
      • Seoul, Korea, Republic of
        Samsung Medical Center, Ilwon-ro 81, Gangnam-gu
      Dec 14, 2022

      Cancer Sensing: Evaluation of Odour Sampling Techniques

      Completed
      • Skin Cancer
      • Solid Phase Microextraction (SPME)
      • Absorptive patch
      • Dorchester, Dorset, United Kingdom
      • +1 more
      Jan 4, 2022

      Alopecia Areata Trial in Assiut (Methotrexate, Triamcinolone Acetonide)

      Not yet recruiting
      • Alopecia Areata
      • Assiut, Egypt
        Al-Azhar University
      Oct 11, 2023

      Advanced and Metastatic Urothelial Cancer Trial in France, Spain, United States (futibatinib and pembrolizumab)

      Recruiting
      • Advanced and Metastatic Urothelial Cancer
      • futibatinib and pembrolizumab
      • San Francisco, California
      • +17 more
      Oct 25, 2022

      Blood Cancer Trial (KCAT19 T cells)

      Not yet recruiting
      • Blood Cancer
      • KCAT19 T cells
      • (no location specified)
      May 20, 2022

      Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide

      Recruiting
      • Unresectable Head and Neck Squamous Cell Carcinoma
      • +2 more
      • BNT113
      • Pembrolizumab
      • Los Angeles, California
      • +79 more
      Jan 9, 2023

      Smoking Cessation, Micronuclei Trial in Switzerland (ENDS (vaporizer/e-cig) and smoking cessation counseling, Smoking cessation

      Active, not recruiting
      • Smoking Cessation
      • Micronuclei
      • ENDS (vaporizer/e-cig) and smoking cessation counseling
      • Smoking cessation counseling
      • Lausanne, Vaud, Switzerland
      • +4 more
      Feb 11, 2022

      Kidney Transplant, Type 2 Diabetes Trial in United States (Empagliflozin)

      Not yet recruiting
      • Kidney Transplant
      • Type 2 Diabetes
      • Iowa City, Iowa
      • +3 more
      Aug 22, 2023

      Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer

      Not yet recruiting
      • Breast Cancer
      • blood sample collection.
      • (no location specified)
      Jan 21, 2021

      Bladder Cancer Trial in Chapel Hill (A personally tailored exercise program)

      Not yet recruiting
      • Bladder Cancer
      • A personally tailored exercise program
      • Chapel Hill, North Carolina
        Lineberger Comphrehensive Cancer Center at University of North C
      Aug 4, 2023

      Cancer Metastatic to Liver, Cancer Colorectal Trial in Copenhagen (Exercise)

      Not yet recruiting
      • Cancer Metastatic to Liver
      • Cancer Colorectal
      • Exercise
      • Copenhagen, Denmark
        Rigshospitalet (CFAS)
      Oct 11, 2022

      Ablation, Liver Resection, and Liver Transplant as First-line

      Completed
      • Hepatocellular Carcinoma
      • Radiofrequency ablation
      • +2 more
      • (no location specified)
      Jan 14, 2022

      Dyslipidemia Trial in Worldwide (Evolocumab, Placebo)

      Completed
      Has Results
      • Dyslipidemia
      • Evolocumab
      • Placebo
      • Birmingham, Alabama
      • +1286 more
      Jul 15, 2022

      Head and Neck Squamous Cell Carcinoma, Lung Cancer, Oesophageal Cancer Trial in Villejuif (Durvalumab, Tremelimumab, SBRT)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +2 more
      • Villejuif, Val De Marne, France
        Gustave Roussy
      Jul 21, 2021

      Evaluation of OE-MRI in Patients With H&N Cancer

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Oxygen Enhanced MRI scan
      • Nottingham, Nottinghamshire, United Kingdom
        Queens Medical Centre
      Sep 30, 2022

      Infant, Extremely Premature, Acute Lung Injury, Chronic Lung Disease of Prematurity Trial in Tucson (Infants in the study group

      Recruiting
      • Infant, Extremely Premature
      • +3 more
      • Infants in the study group (S/B group) will receive surfactant 2.5 mls/kg and Budesonide 0.5 mg (1mL)
      • Infants in the control group (S/P group) receive placebo (Normal saline 1mL)
      • Tucson, Arizona
        University of Arizona
      Oct 31, 2022

      Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial

      Recruiting
      • Metastatic Distal Bile Duct Adenocarcinoma
      • +9 more
      • Atezolizumab
      • +6 more
      • Phoenix, Arizona
      • +28 more
      Dec 31, 2022